阿尔多基托减小酶-7A2通过Nrf2激活来保护阿托瓦斯塔丁诱导的肝毒性
Dan Li1, Jiajin Chen1, Fei Zhou1
1Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, 310014, China.
Chemico-biological interactions
|March 14, 2024
概括
这项研究表明,Nrf2介导的AKR7A2通路保护肝细胞免受阿托瓦斯塔丁过量损伤. 提高AKR7A2的调节可以减轻阿托瓦斯塔丁诱导的肝毒性,这为抗药副作用提供了潜在的策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿托瓦斯塔丁 (ATO) 是一种广泛使用的降胆固醇药物.
- 过量服用ATO可以导致肝脏和肌肉损伤,与氧化应激和脂质过氧化有关.
- 了解抗ATO诱导的肝毒性保护机制对于患者安全至关重要.
研究的目的:
- 调查抗氧化途径和酶在防止ATO诱导的肝损伤方面的作用.
- 阐明Nrf2通路和AKR7A酶在细胞对ATO暴露的反应中的参与.
主要方法:
- 使用的HepG2细胞受到阿托瓦斯塔丁的挑战.
- 评估了Nrf2和AKR7A2.2的表达水平.
- 使用的药理抑制和 Nrf2.2 的遗传失活化.
- 进行基因淘汰和过度表达AKR7A2.2.
主要成果:
- 在HepG2细胞中的Nrf2表达上调.
- 抑制或禁用Nrf2加剧的ATO诱导的细胞毒性.
- ATO暴露增加了AKR7A2.2.的mRNA水平.
- Knockdown 的 AKR7A2 恶化 ATO 诱导的肝毒性,而过度表达减轻了它.
- AKR7A2的保护作用取决于Nrf2.
结论:
- 通过高度的阿托瓦斯塔丁激活了Nrf2介导的AKR7A2通路.
- AKR7A2在保护ATO诱导的肝毒性方面发挥着重要作用.
- AKR7A2是缓解阿托瓦斯塔丁相关肝损伤的潜在治疗标.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
660
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
660
01:24Peroxisomes
12.3K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
12.3K
01:23Protecting Groups for Aldehydes and Ketones: Introduction
7.0K
Protecting groups are compounds that can bind to a specific functional group in the presence of other functional groups to protect them from undesired chemical reactions. These compounds can selectively bind to particular functional groups and advance chemoselective reactions in polyfunctional systems (Figure 1). After the functional group has served its purpose, it is removed by reacting it with specific compounds.
7.0K
01:31Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
01:24Acetals and Thioacetals as Protecting Groups for Aldehydes and Ketones
4.2K
Acetals are formed by reacting two equivalents of alcohol with carbonyl compounds like aldehydes or ketones. Acetals are unaffected by bases, nucleophiles, oxidizing agents, and reducing agents. They serve as protecting groups for aldehydes and ketones. Acetals can be easily formed and also easily removed via mild acid hydrolysis.
In the presence of multiple functional groups, when selective reduction of one group over the other is desired, groups like aldehydes and ketones that form acetals...
In the presence of multiple functional groups, when selective reduction of one group over the other is desired, groups like aldehydes and ketones that form acetals...
4.2K
01:19Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K